We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-4.26%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$15.9B
AUM Growth
-$1.2B
Cap. Flow
-$334M
Cap. Flow %
-2.11%
Top 10 Hldgs %
20.24%
Holding
1,417
New
118
Increased
414
Reduced
584
Closed
141

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$49.8M
2
WBD icon
Warner Bros
WBD
+$47.5M
3
PYPL icon
PayPal
PYPL
+$41.8M
4
GPC icon
Genuine Parts
GPC
+$39.6M
5
MOS icon
The Mosaic Company
MOS
+$38.4M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$59M
2
TGT icon
Target
TGT
+$55.8M
3
AMAT icon
Applied Materials
AMAT
+$51.1M
4
IT icon
Gartner
IT
+$49.5M
5
NVDA icon
NVIDIA
NVDA
+$38.9M

Sector Composition

Rank Sector Weight
1 Technology 20.54%
2 Healthcare 14.44%
3 Financials 10.72%
4 Consumer Discretionary 8.82%
5 Industrials 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTUM icon
901
iShares MSCI USA Momentum Factor ETF
MTUM
$23.6B
$356K ﹤0.01%
2,720
+221
+9% +$31K
CHKP icon
902
Check Point Software Technologies
CHKP
$14.3B
$355K ﹤0.01%
3,176
+30
+1% +$3.63K
PHG icon
903
Philips
PHG
$25.5B
$355K ﹤0.01%
27,047
-3,939
-13% -$64K
MWA icon
904
Mueller Water Products
MWA
$3.94B
$354K ﹤0.01%
34,547
-1,192
-3% -$13.9K
HLI icon
905
Houlihan Lokey
HLI
$9.72B
$353K ﹤0.01%
+4,687
New +$380K
DXCM icon
906
DexCom
DXCM
$29B
$350K ﹤0.01%
+4,356
New +$369K
BSX icon
907
Boston Scientific
BSX
$68.4B
$349K ﹤0.01%
+9,055
New +$363K
ESNT icon
908
Essent Group
ESNT
$6.28B
$348K ﹤0.01%
10,000
-14
-0.1% -$561
FORM icon
909
FormFactor
FORM
$6.51B
$348K ﹤0.01%
+13,932
New +$452K
MRVI icon
910
Maravai LifeSciences
MRVI
$972M
$347K ﹤0.01%
13,598
-24,376
-64% -$612K
IOO icon
911
iShares Global 100 ETF
IOO
$8.62B
$346K ﹤0.01%
5,822
CFR icon
912
Cullen/Frost Bankers
CFR
$10.5B
$343K ﹤0.01%
2,600
-18
-0.7% -$2.36K
EQH icon
913
Equitable Holdings
EQH
$13.2B
$342K ﹤0.01%
13,018
-634
-5% -$18K
DAL icon
914
Delta Air Lines
DAL
$56.7B
$341K ﹤0.01%
+12,175
New +$387K
CYRX icon
915
CryoPort
CYRX
$753M
$338K ﹤0.01%
13,904
-7,104
-34% -$245K
SIGI icon
916
Selective Insurance
SIGI
$5.76B
$338K ﹤0.01%
4,156
-398
-9% -$32.4K
HRL icon
917
Hormel Foods
HRL
$14.2B
$337K ﹤0.01%
7,454
-195
-3% -$9.42K
ONTO icon
918
Onto Innovation
ONTO
$10.9B
$337K ﹤0.01%
5,267
-2,934
-36% -$216K
SNY icon
919
Sanofi
SNY
$107B
$336K ﹤0.01%
8,887
-5,723
-39% -$255K
HAS icon
920
Hasbro
HAS
$13.5B
$332K ﹤0.01%
4,935
-522
-10% -$41.2K
PLUS icon
921
ePlus
PLUS
$2.43B
$331K ﹤0.01%
7,977
+244
+3% +$11.9K
SON icon
922
Sonoco
SON
$5.83B
$330K ﹤0.01%
5,831
-1,149
-16% -$70.6K
ETR icon
923
Entergy
ETR
$50.3B
$329K ﹤0.01%
+6,554
New +$376K
TTWO icon
924
Take-Two Interactive
TTWO
$46.1B
$328K ﹤0.01%
3,017
+165
+6% +$20.5K
VOD icon
925
Vodafone
VOD
$37.1B
$326K ﹤0.01%
28,885
-20
-0.1% -$279

Similar funds

Glenmede Trust's Q3 2022 Portfolio in Review

As of Q3 2022, Glenmede Trust held 1,417 positions worth $15.9B, down 7% from $17.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Glenmede Trust's Q3 2022 filing shows 118 new, 414 increased, 584 reduced and 141 closed positions. Its largest new stake was Privia Health: 119,083 shares worth $4.05M. The largest sale was Meta Platforms (Facebook), an estimated $59M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2022 buy was Privia Health: 119,083 shares worth $4.05M.
  • Glenmede Trust added most to Kellanova in Q3 2022, an estimated $49.8M increase.
  • Glenmede Trust's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $59M.
  • Glenmede Trust fully exited Atlas Air Worldwide Holdings, Inc. in Q3 2022, selling an estimated $15.5M.
  • Glenmede Trust's ten largest holdings make up 20% of its $15.9B portfolio in Q3 2022.
  • Glenmede Trust opened 118 new positions and closed 141 in Q3 2022.
  • Glenmede Trust's portfolio value fell 7% quarter-over-quarter to $15.9B.

Based on Glenmede Trust's 13F filing for Q3 2022, filed 16 Nov 2022.